HealthTree®

IMPROVING MYELOMA PATIENT OUTCOMES AND ACCELERATING A CURE

LIFE WITH MYELOMA

Patient Power: Cherie Rineker’s Post-CAR T-Cell Tri...

May 18, 2018
Multiple myeloma patient Cherie Rineker gives Patient Power an inside look into her experience with CAR T-cell clinical trial. She shares the highs and lows of being in a clinical trial and provides insight...
ADVERTISEMENT
CLINICAL TRIALS

Clinical Trial: BOSTON Trial, Bortezomib, Selinexor, and ...

May 18, 2018
The BOSTON trial is a phase 3 study comparing weekly oral selinexor + bortezomib + low-dose dexamethasone (SVd) versus bortezomib (twice weekly) + low-dose dexametha...
SIGN UP FOR OUR
NEWSLETTER
Get the latest thought leadership on multiple myeloma delivered straight to your inbox.

GO

LIFE WITH MYELOMA
May 15, 2018
TerraCycle is a company that reuses, upcycles,...
MYELOMA CROWD RADIO

Full Show: Introducing HealthTree for Multiple Myeloma Pa...

May 22, 2018
Rafael Fonseca, MD Mayo Clinic Scottsdale Interview...
MYELOMA CROWD RESEARCH INITIATIVE
$49,561 of $500,000 Raised
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal
MYELOMA 101

Myeloma 101: How Immunomodulators Wor...

Jan 11, 2018
The story of Immunomodulatory drugs for the treatment of multiple myeloma is one of serendipity. The immunomodulatory drug thalidomide was used in the 1950...
MUSCLES FOR MYELOMA

Myeloma Crowd Cycling Club – Join Us Today!

Apr 09, 2018
We'd like to invite you to join the new Myeloma Crowd Cycling Club! Avid cyclist and myeloma patient, Richard Hite, and the Myeloma Crowd team created this...
CLINICAL TRIALS

Clinical Trials: What are Bispecific Antibodies?

May 07, 2018
Immunotherapy is a method of treating cancer that uses the body’s immune system to fight the cancer cells. A bispecific antibody is a type of immunotherapy being tested for use in the treatment of Multiple Myeloma. It differs from traditional monoclonal antibodies in that it...

FIND

Myeloma Financial Resource
FINANCIAL
RESOURCES
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
Myeloma Specialist
MYELOMA
SPECIALISTS
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.
Myeloma Clinical Trials
CLINICAL
TRIALS
Today's myeloma therapies are yesterday's clinical trials and if more patients joined, we could accelerate a cure.Find a trial that's right for you using a myeloma clinical trial finder called SparkCures.

MYELOMA CROWD RESEARCH INITIATIVE

The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. The goal of the MCRI is to find and fund a cure for multiple myeloma.
Learn More >

Thanks to our site sponsors: